This federal Project Grant award of $858,000.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports a longitudinal analysis of the mesenchymal cell state from melanoma initiation to metastatic progression at Thomas Jefferson University's Sidney Kimmel Medical College. The award, effective August 1, 2024, with a completion date of July 31, 2027, funds advanced biomedical research aimed at transforming healthcare for...
The Department of the Army Medical Command awarded Thomas Jefferson University a $841,473 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop occult colorectal cancer elimination through GUCY2C-directed immunotherapy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Defense Health Agency awarded a $756,897 Project Grant to Thomas Jefferson University, doing business as the Sidney Kimmel Medical College, for the federal grant program "Military Medical Research and Development" (CFDA 12.420). The grant, effective August 1, 2024 through July 31, 2027, will support "Second-Generation Precision Medicine for BRCA-Mutant Ovarian Cancer" research. Thomas Jefferson University, a leading academic medical center known for its innovative medical...
Thomas Jefferson University will receive $3,052,929 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to research occult colorectal cancer elimination by GUCY2C-directed immunotherapy from July 1, 2022 to June 30, 2026. Specifically, the Sidney Kimmel Medical College of Thomas Jefferson University will investigate medical solutions for the battlefield and transform healthcare for service members and the public through...
The Defense Health Agency awarded a $312,000 Project Grant to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to conduct research on "Inhibiting Mitochondrial Permeability Transition Pore Opening to Treat Mitochondrial Myopathy" over the period of September 1, 2023 to August 31, 2025. This grant was provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to...
The Department of the Army Medical Command awarded a $802,843 Project Grant to Thomas Jefferson University under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2021 through May 31, 2025. The grant funds a precision medicine research project utilizing patient-derived xenograft models of serous ovarian cancer to investigate methyl CpG binding protein 2 (MECP2) overexpression as a potential biomarker and dependency. Researchers will screen tissue...
Thomas Jefferson University, doing business as Sidney Kimmel Medical College, was awarded a $234,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund research into precision therapies for metastatic uveal melanoma prevention and treatment by investigating multimodal GNAQ signaling pathways. Through September 2021 to August 2024, Sidney Kimmel Medical College researchers will work to transform...
The Defense Health Agency awarded Thomas Jefferson University a $779,200 project grant under the Military Medical Research and Development program (CFDA 12.420) to conduct senotherapy research for amyotrophic lateral sclerosis (ALS) from April 1, 2023 through March 31, 2025. The grant will support basic, applied, and advanced biomedical research investigating medical solutions for ALS, consistent with the program's goals of transforming military and public health care through innovative...
This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $725,001.00 to Thomas Jefferson University - Sidney Kimmel Medical College to conduct research aimed at "Improving Wound Healing and Recovery by Blocking Excessive Scar Formation in Peripheral Nerves, Muscles, and Joints After Composite Injuries to Extremities." The research, which will take place in Philadelphia, PA, is intended to transform healthcare for service...
This $802,068 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of California, San Diego (UCSD) to investigate how sublethal apoptotic signaling promotes melanoma adaptation to immune attack. The research aims to transform health care for service members and the broader public through innovative and impactful biomedical studies. The grant provides funding for UCSD's...